Welcure Drugs & Pharmaceuticals Ltd. reported unaudited earnings results for third quarter and nine months ended December 31, 2013. For the quarter, the company's loss from operations before other income, finance cost and exceptional items were INR 0.044 million compared to INR 0.034 million a year ago. Loss from ordinary activities before tax was INR 0.044 million compared to INR 0.034 million a year ago. Net loss was INR 0.044 million compared to INR 0.034 million or INR 0.01 per share for the same period a year ago.

For the nine months, the company's loss from operations before other income, finance cost and exceptional items were INR 0.375 million compared to INR 0.341 million a year ago. Loss from ordinary activities before tax was INR 0.254 million compared to INR 0.131 million a year ago. Net loss was INR 0.254 million compared to INR 0.131 million for the same period a year ago.